163 related articles for article (PubMed ID: 37419985)
1. Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function.
Jiang X; Peng J; Xie Y; Xu Y; Liu Q; Cheng C; Yan P; Xu S; Wang Y; Zhang L; Li H; Li Y; Li B; Han J; Yu D
Cell Death Differ; 2023 Aug; 30(8):1931-1942. PubMed ID: 37419985
[TBL] [Abstract][Full Text] [Related]
2. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
3. OGDHL is a modifier of AKT-dependent signaling and NF-κB function.
Sen T; Sen N; Noordhuis MG; Ravi R; Wu TC; Ha PK; Sidransky D; Hoque MO
PLoS One; 2012; 7(11):e48770. PubMed ID: 23152800
[TBL] [Abstract][Full Text] [Related]
4. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis.
Liu Y; Meng F; Wang J; Liu M; Yang G; Song R; Zheng T; Liang Y; Zhang S; Yin D; Wang J; Yang H; Pan S; Sun B; Han J; Sun J; Lan Y; Wang Y; Liu X; Zhu M; Cui Y; Zhang B; Wu D; Liang S; Liu Y; Song X; Lu Z; Yang J; Li M; Liu L
Clin Cancer Res; 2019 Sep; 25(17):5407-5421. PubMed ID: 31175094
[TBL] [Abstract][Full Text] [Related]
5.
Jiao Y; Li Y; Fu Z; Hou L; Chen Q; Cai Y; Jiang P; He M; Yang Z
Dis Markers; 2019; 2019():9037131. PubMed ID: 31781311
[TBL] [Abstract][Full Text] [Related]
6. Novel isoenzyme of 2-oxoglutarate dehydrogenase is identified in brain, but not in heart.
Bunik V; Kaehne T; Degtyarev D; Shcherbakova T; Reiser G
FEBS J; 2008 Oct; 275(20):4990-5006. PubMed ID: 18783430
[TBL] [Abstract][Full Text] [Related]
7. Silencing of OGDHL promotes liver cancer metastasis by enhancing hypoxia inducible factor 1 α protein stability.
Dai W; Li Y; Sun W; Ji M; Bao R; Chen J; Xu S; Dai Y; Chen Y; Liu W; Ge C; Sun W; Mo W; Guo C; Xu X
Cancer Sci; 2023 Apr; 114(4):1309-1323. PubMed ID: 36000493
[TBL] [Abstract][Full Text] [Related]
8. OGDHL ameliorates cognitive impairment and Alzheimer's disease-like pathology via activating Wnt/β-catenin signaling in Alzheimer's disease mice.
Yao L; Xu X; Xu Y; Li C; Xie F; Guo M; Liu Z; Liu X
Behav Brain Res; 2022 Feb; 418():113673. PubMed ID: 34798170
[TBL] [Abstract][Full Text] [Related]
9. The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.
Shi J; Miao D; Lv Q; Wang K; Wang Q; Liang H; Yang H; Xiong Z; Zhang X
Cell Death Dis; 2023 Aug; 14(8):560. PubMed ID: 37626050
[TBL] [Abstract][Full Text] [Related]
10. Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Zhang Q; Wei T; Jin W; Yan L; Shi L; Zhu S; Bai Y; Zeng Y; Yin Z; Yang J; Zhang W; Wu M; Zhang Y; Peng G; Roessler S; Liu L
J Hepatol; 2024 Feb; 80(2):293-308. PubMed ID: 38450598
[TBL] [Abstract][Full Text] [Related]
11. OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer.
Mao M; Huang RZ; Zheng J; Liang HQ; Huang WH; Liu J; Li JH
Cancer Med; 2021 Jan; 10(2):728-736. PubMed ID: 33405394
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.
Yousefi K; Irion CI; Takeuchi LM; Ding W; Lambert G; Eisenberg T; Sukkar S; Granzier HL; Methawasin M; Lee DI; Hahn VS; Kass DA; Hatzistergos KE; Hare JM; Webster KA; Shehadeh LA
J Am Coll Cardiol; 2019 Jun; 73(21):2705-2718. PubMed ID: 31146816
[TBL] [Abstract][Full Text] [Related]
13. Aberrant hypermethylation of OGDHL gene promoter in sporadic colorectal cancer.
Khalaj-Kondori M; Hosseinnejad M; Hosseinzadeh A; Behroz Sharif S; Hashemzadeh S
Curr Probl Cancer; 2020 Feb; 44(1):100471. PubMed ID: 30904169
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity.
Lin SJ; Vona B; Lau T; Huang K; Zaki MS; Aldeen HS; Karimiani EG; Rocca C; Noureldeen MM; Saad AK; Petree C; Bartolomaeus T; Abou Jamra R; Zifarelli G; Gotkhindikar A; Wentzensen IM; Liao M; Cork EE; Varshney P; Hashemi N; Mohammadi MH; Rad A; Neira J; Toosi MB; Knopp C; Kurth I; Challman TD; Smith R; Abdalla A; Haaf T; Suri M; Joshi M; Chung WK; Moreno-De-Luca A; Houlden H; Maroofian R; Varshney GK
Genome Med; 2023 Nov; 15(1):102. PubMed ID: 38031187
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
Ding H; Liu J; Zou R; Cheng P; Su Y
J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
[TBL] [Abstract][Full Text] [Related]
16. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma.
Zhou Q; Lin J; Yan Y; Meng S; Liao H; Chen R; He G; Zhu Y; He C; Mao K; Wang J; Zhang J; Zhou Z; Xiao Z
J Exp Clin Cancer Res; 2022 Jan; 41(1):13. PubMed ID: 34996491
[TBL] [Abstract][Full Text] [Related]
17.
Huang XF; Sheu GT; Chang KF; Huang YC; Hung PH; Tsai NM
Molecules; 2020 Nov; 25(23):. PubMed ID: 33266043
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma.
Yang H; Zhao X; Zhao L; Liu L; Li J; Jia W; Liu J; Huang G
Oncotarget; 2016 Nov; 7(44):72131-72147. PubMed ID: 27708221
[TBL] [Abstract][Full Text] [Related]
19. Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia.
Yap ZY; Efthymiou S; Seiffert S; Vargas Parra K; Lee S; Nasca A; Maroofian R; Schrauwen I; Pendziwiat M; Jung S; Bhoj E; Striano P; Mankad K; Vona B; Cuddapah S; Wagner A; Alvi JR; Davoudi-Dehaghani E; Fallah MS; Gannavarapu S; Lamperti C; Legati A; Murtaza BN; Nadeem MS; Rehman MU; Saeidi K; Salpietro V; von Spiczak S; Sandoval A; Zeinali S; Zeviani M; Reich A; ; ; Jang C; Helbig I; Barakat TS; Ghezzi D; Leal SM; Weber Y; Houlden H; Yoon WH
Am J Hum Genet; 2021 Dec; 108(12):2368-2384. PubMed ID: 34800363
[TBL] [Abstract][Full Text] [Related]
20. Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.
Hu H; Xu L; Luo SJ; Xiang T; Chen Y; Cao ZR; Zhang YJ; Mo Z; Wang Y; Meng DF; Yu L; Lin LZ; Zhang SJ
Int J Med Sci; 2020; 17(13):1897-1908. PubMed ID: 32788868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
